Pharmacogenetic testing affects choice of therapy among women considering tamoxifen treatment

BACKGROUND: Pharmacogenetic testing holds major promise in allowing physicians to tailor therapy to patients based on genotype. However, there is little data on the impact of pharmacogenetic test results on patient and clinician choice of therapy. CYP2D6 testing among tamoxifen users offers a potent...

Descripción completa

Detalles Bibliográficos
Autores principales: Lorizio, Wendy, Rugo, Hope, Beattie, Mary S, Tchu, Simone, Melese, Teri, Melisko, Michelle, Wu, Alan HB, Lawrence, H Jeffrey, Nikoloff, Michele, Ziv, Elad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3239226/
https://www.ncbi.nlm.nih.gov/pubmed/21970596
http://dx.doi.org/10.1186/gm280

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3239226/
https://www.ncbi.nlm.nih.gov/pubmed/21970596
http://dx.doi.org/10.1186/gm280

Ejemplares similares